“We are excited to increase the market penetration of these products through significant investment in domestic and international selling resources, select product enhancements, and new product development,” Greg Groenke, CEO of IZI Medical, said in a prepared statement.

“We were looking for a company that could invest more resources and continue to support these product families, the patients that benefit from them, and the physicians that use them,” Mark Breedlove, vice president of the vascular division at Cook Medical, said in the same statement.

Breedlove added that Cook Medical has worked with IZI previously and determined they would be the “ideal partner” for such a partnership.